share_log

NovaBay Pharmaceuticals | 8-K: NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

NovaBay Pharmaceuticals | 8-K: Current report

NovaBay Pharmaceuticals | 8-K:重大事件
美股SEC公告 ·  2024/03/14 08:34
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息